Stay updated on Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.

Latest updates to the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page
- CheckyesterdayChange DetectedThe revision label on the page updated from v3.6.5 to v3.6.6, reflecting a newer page revision in the site’s metadata. This change does not alter content or behavior.SummaryDifference0.0%

- Check8 days agoChange DetectedA new funding/identifier line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, signaling NIH support for the trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows a new revision tag, v3.6.5, replacing v3.6.4, indicating a behind-the-scenes update to the page templates or site components rather than changes to the study details.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small, technical update to the page rather than a substantive change to the study information.SummaryDifference0.0%

- Check58 days agoChange DetectedDeployment of a new site revision (v3.6.3) replacing the previous version (v3.6.2). This appears to be a minor maintenance update and does not reflect changes to the study details or visible content on the page.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer page revision.SummaryDifference0.0%

Stay in the know with updates to Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.